Nucleic Acid Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Consumables, Systems, Accessories & Components), By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others), By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others), By Application (Genomics, Proteomics, Others), By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other), By Region & Competition, 2021-2031F

May 2026 | 185 pages | ID: N56F0465508DEN
TechSci Research

Abstracts

The Global Nucleic Acid Sample Preparation Market is projected to expand from USD 2.99 Billion in 2025 to USD 4.41 Billion by 2031, achieving a 6.69% Compound Annual Growth Rate. This market centers on the extraction, isolation, and purification of DNA and RNA from biological samples to yield high-quality material for critical downstream analytical uses like amplification and sequencing.

Market Driver

Key drivers for this expansion include the rising incidence of infectious diseases and cancer, demanding extensive molecular diagnostic testing, and the burgeoning field of precision medicine, which requires reliable, high-purity nucleic acid extraction for accurate genomic profiling. The substantial demand for sample processing within biopharmaceutical research is further evidenced by over 8,000 medicines in clinical development in 2024. Furthermore, the increasing adoption of Next-Generation Sequencing and molecular diagnostics is fueling market growth by imposing stringent quality standards on extracted nucleic acids for generating reliable data in areas such as liquid biopsy.

Market Challenge

Despite these robust growth factors, the Global Nucleic Acid Sample Preparation Market faces a significant impediment due to the high capital investment required for automated nucleic acid extraction platforms. This substantial initial expenditure often proves prohibitive for smaller laboratories and diagnostic centers, which are then compelled to rely on less efficient, labor-intensive manual extraction methods. Such budgetary constraints directly limit market penetration for advanced technologies and concentrate their adoption within larger, well-funded reference laboratories. Evidence from the American Hospital Association in 2025 indicates that 94% of healthcare administrators anticipated delaying equipment upgrades due to persistent financial strain, underscoring how this widespread deferral of capital projects impedes the market by extending the lifecycle of legacy equipment rather than fostering investment in modern automated workflows essential for scaling genomic profiling and diagnostic testing.

Market Trends

Complementing this growth, the market is experiencing an increase in the adoption of automated liquid handling workstations, which enhance reproducibility and operational efficiency by standardizing nucleic acid yields and reducing manual effort, alongside the development of high-precision kits for single-cell genomics, critical for isolating genetic material from individual cells for advanced applications in immunology and spatial biology.

Key Market Players

• BGI Group
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Eppendorf SE
• BIONEER CORPORATION
• Endress+Hauser Group Services AG
• Merck KGaA
• Norgen Biotek Corp.
• Aurora Biomed Inc.
• Agilent Technologies, Inc.

Report Scope

In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Nucleic Acid Sample Preparation Market, By Product
• Consumables
• Systems
• Accessories & Components
• Nucleic Acid Sample Preparation Market, By Technology
• Spin-Column Based Technology
• Magnetic-Bead Based Technology
• Others
• Nucleic Acid Sample Preparation Market, By Therapeutic Area
• Oncology
• Infectious Disease
• Human Genetics/Population Genetics
• Others
• Nucleic Acid Sample Preparation Market, By Application
• Genomics
• Proteomics
• Others
• Nucleic Acid Sample Preparation Market, By End Users
• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Clinical and Diagnostic Laboratories
• Other
• Nucleic Acid Sample Preparation Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.

Available Customizations:

Global Nucleic Acid Sample Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Consumables, Systems, Accessories & Components)
  5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
  5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
  5.2.4. By Application (Genomics, Proteomics, Others)
  5.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
  5.2.6. By Region
  5.2.7. By Company (2025)
5.3. Market Map

6. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Technology
  6.2.3. By Therapeutic Area
  6.2.4. By Application
  6.2.5. By End Users
  6.2.6. By Country
6.3. North America: Country Analysis
  6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By Technology
      6.3.1.2.3. By Therapeutic Area
      6.3.1.2.4. By Application
      6.3.1.2.5. By End Users
  6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By Technology
      6.3.2.2.3. By Therapeutic Area
      6.3.2.2.4. By Application
      6.3.2.2.5. By End Users
  6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By Technology
      6.3.3.2.3. By Therapeutic Area
      6.3.3.2.4. By Application
      6.3.3.2.5. By End Users

7. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Technology
  7.2.3. By Therapeutic Area
  7.2.4. By Application
  7.2.5. By End Users
  7.2.6. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Technology
      7.3.1.2.3. By Therapeutic Area
      7.3.1.2.4. By Application
      7.3.1.2.5. By End Users
  7.3.2. France Nucleic Acid Sample Preparation Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Technology
      7.3.2.2.3. By Therapeutic Area
      7.3.2.2.4. By Application
      7.3.2.2.5. By End Users
  7.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Technology
      7.3.3.2.3. By Therapeutic Area
      7.3.3.2.4. By Application
      7.3.3.2.5. By End Users
  7.3.4. Italy Nucleic Acid Sample Preparation Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Technology
      7.3.4.2.3. By Therapeutic Area
      7.3.4.2.4. By Application
      7.3.4.2.5. By End Users
  7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Technology
      7.3.5.2.3. By Therapeutic Area
      7.3.5.2.4. By Application
      7.3.5.2.5. By End Users

8. ASIA PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Technology
  8.2.3. By Therapeutic Area
  8.2.4. By Application
  8.2.5. By End Users
  8.2.6. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Nucleic Acid Sample Preparation Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Technology
      8.3.1.2.3. By Therapeutic Area
      8.3.1.2.4. By Application
      8.3.1.2.5. By End Users
  8.3.2. India Nucleic Acid Sample Preparation Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Technology
      8.3.2.2.3. By Therapeutic Area
      8.3.2.2.4. By Application
      8.3.2.2.5. By End Users
  8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Technology
      8.3.3.2.3. By Therapeutic Area
      8.3.3.2.4. By Application
      8.3.3.2.5. By End Users
  8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Technology
      8.3.4.2.3. By Therapeutic Area
      8.3.4.2.4. By Application
      8.3.4.2.5. By End Users
  8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Technology
      8.3.5.2.3. By Therapeutic Area
      8.3.5.2.4. By Application
      8.3.5.2.5. By End Users

9. MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Technology
  9.2.3. By Therapeutic Area
  9.2.4. By Application
  9.2.5. By End Users
  9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Technology
      9.3.1.2.3. By Therapeutic Area
      9.3.1.2.4. By Application
      9.3.1.2.5. By End Users
  9.3.2. UAE Nucleic Acid Sample Preparation Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Technology
      9.3.2.2.3. By Therapeutic Area
      9.3.2.2.4. By Application
      9.3.2.2.5. By End Users
  9.3.3. South Africa Nucleic Acid Sample Preparation Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Technology
      9.3.3.2.3. By Therapeutic Area
      9.3.3.2.4. By Application
      9.3.3.2.5. By End Users

10. SOUTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Technology
  10.2.3. By Therapeutic Area
  10.2.4. By Application
  10.2.5. By End Users
  10.2.6. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Technology
      10.3.1.2.3. By Therapeutic Area
      10.3.1.2.4. By Application
      10.3.1.2.5. By End Users
  10.3.2. Colombia Nucleic Acid Sample Preparation Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Technology
      10.3.2.2.3. By Therapeutic Area
      10.3.2.2.4. By Application
      10.3.2.2.5. By End Users
  10.3.3. Argentina Nucleic Acid Sample Preparation Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Technology
      10.3.3.2.3. By Therapeutic Area
      10.3.3.2.4. By Application
      10.3.3.2.5. By End Users

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. BGI Group
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. F. Hoffmann-La Roche Ltd
15.3. Danaher Corporation
15.4. Eppendorf SE
15.5. BIONEER CORPORATION
15.6. Endress+Hauser Group Services AG
15.7. Merck KGaA
15.8. Norgen Biotek Corp.
15.9. Aurora Biomed Inc.
15.10. Agilent Technologies, Inc.

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER